Skip to main content
      RT @Yuz6Yusof: The #Lupus Faculty @RheumNow is proud to share our latest video about learning points from a jam-packed d

      Md Yuzaiful Md Yusof Yuz6Yusof

      4 years ago
      The #Lupus Faculty @RheumNow is proud to share our latest video about learning points from a jam-packed day at #ACR21 https://t.co/LRyuYyHlhi @KDAO2011 @Janetbirdope @bella_mehta @_Castillo_Pedro
      RT @LCalabreseDO: #ACR21 Ignaki Sanz makes the case that +++ AUTOANTIBODIES are integrally involved in #COVID19 immunopa

      Leonard Calabrese LCalabreseDO

      4 years ago
      #ACR21 Ignaki Sanz makes the case that +++ AUTOANTIBODIES are integrally involved in #COVID19 immunopathogeneisis and may rise and fall w disease states- TBD what role they play in acute disease and #LongCovid @CCalabreseDO @VirusesImmunity @CleClinicMD #COVID19AB https://t.co/9dzCSh5V7R
      The arsenal of therapeutics for psoriatic arthritis continues to increase. Risankizumab is an IL-23 inhibitor to the p19 subunit, currently being investigated for treatment of psoriatic arthritis.
      The opening of ACR2 Convergence was a hit for all who signed up and viewed in. The day included the presidential address by outgoing president Dr. David Karp (UT Southwestern) and a keynote talk and interview with Dr. Seema Yasmin (Stanford). The Year in Review featured a clinical vs basic science Brigham and Women’s Hospital faceoff between its two faculty, Dr. Karen Costenbader and Dr. Michael Brenner.
      RT @KDAO2011: "The time for young people is now! You are not the future, you are the present; you can make a difference.

      TheDaoIndex KDAO2011

      4 years ago
      "The time for young people is now! You are not the future, you are the present; you can make a difference. You may be scared, but take the opportunities and be purposeful." -Dr. A Alakija on the role of young rheumatologists in global health disparities #ACR21 @ACRheum @yodifiji
      RT @KDAO2011: Dr. Marvisi presented a case: refractory MPA relapsed w/prednisone < 25 mg/day. Genetic studies c/w VEX

      TheDaoIndex KDAO2011

      4 years ago
      Dr. Marvisi presented a case: refractory MPA relapsed w/prednisone < 25 mg/day. Genetic studies c/w VEXAS. Is MPA/vasculitis part of VEXAS? The experts say: Maybe- VEXAS is such a new entity, there may be a common pathway (e.g NFkB affected by ubiquination, IL-6 role) #ACR21 https://t.co/kEOsruJ8DE
      Appropriate assessment and management of comorbidities and multimorbidity in patients with RA is vital for overall health and well-being of the patient, as well as to encourage treatment adherence, and address social, psychological and quality of life factors. 
      RT @KDAO2011: She was considered a "high risk hire" b/c of her accent, being young, and being a mother of 3 children who

      TheDaoIndex KDAO2011

      4 years ago
      She was considered a "high risk hire" b/c of her accent, being young, and being a mother of 3 children who still needs her. -Dr. Graciela Alarcon, a giant in rheumatology,talked about her life in the Global Women Leaders in Rheumatology #ACR21 @ACRheum @rheumnow #strongwomen https://t.co/Oxmy8ruIZF
      RT @KDAO2011: Solutions to the Gender Gap:
      👉treat gender equality as an innovation challenge requiring innovative sol

      TheDaoIndex KDAO2011

      4 years ago
      Solutions to the Gender Gap: 👉treat gender equality as an innovation challenge requiring innovative solutions 👉create culture where people feel personally responsible for change (not coerced) 👉implement action plans to support behavioral changes with measurable targets #ACR21 https://t.co/BrExrHx1S7
      RT @KDAO2011: My typo: * patience (but "patients" are needed too for a rheum career)

      TheDaoIndex KDAO2011

      4 years ago
      My typo: * patience (but "patients" are needed too for a rheum career)
      RT @KDAO2011: Drs. Alarcon, Hajjaj-Hassouni, Aggarwal, and March are trailblazers for #WomeninRheum. Sage advice: "The p

      TheDaoIndex KDAO2011

      4 years ago
      Drs. Alarcon, Hajjaj-Hassouni, Aggarwal, and March are trailblazers for #WomeninRheum. Sage advice: "The people who open doors may be you." "Sometimes, you have to create your own opportunity." "Push your ideas, don't just watch." #ACR21 @acrheum @LauraLewMad11 moderates panel https://t.co/gxmjntDQst
      RT @KDAO2011: Dr. P Krause (FDA/CBER Deputy Dir., Office of Vaccine Research and Review) on #COVIDvaccine in kids:
      👉C

      TheDaoIndex KDAO2011

      4 years ago
      Dr. P Krause (FDA/CBER Deputy Dir., Office of Vaccine Research and Review) on #COVIDvaccine in kids: 👉Children respond to vaccine better than adults; can use lower doses 👉the lower dose will mitigate safety concerns (FDA gave EUA for Pfizer vaccine for 5-11 yo) #ACR21 https://t.co/Z7kcYQKZ8S
      RheumNow’s expanded coverage of the #ACR21 meeting is sponsored in part by @Novartis. All content chosen by RheumNow &

      Dr. John Cush RheumNow

      4 years ago
      RheumNow’s expanded coverage of the #ACR21 meeting is sponsored in part by @Novartis. All content chosen by RheumNow & its Faculty.
      RT @KDAO2011: 👉 anti-CK Ab may be a cause of #LongCovid syndrome
      👉found in patients with autoimmune (SLE/Sjogrens)

      TheDaoIndex KDAO2011

      4 years ago
      👉 anti-CK Ab may be a cause of #LongCovid syndrome 👉found in patients with autoimmune (SLE/Sjogrens) and can affect dz severity. 👉has not been seen in children 2/2 #ACR21
      RT @KDAO2011: Role of anti-CK antibodies:
      👉⬆️susceptibility to severe mycobacterial dz &amp; opportunistic infx

      TheDaoIndex KDAO2011

      4 years ago
      Role of anti-CK antibodies: 👉⬆️susceptibility to severe mycobacterial dz & opportunistic infx (similar to HIV) 👉causes an indeterminate quantiferon (no response to mitogen) 👉initiated by infx➡️anti-Noc2 Ab➡️cross react with IFN➡️IFN-Ab 👉⬆️severity of #COVID19 #ACR21 1/2 https://t.co/5NHQpwQw6X
      ×